Clinical Spectrum Associated with Wolfram Syndrome Type 1 and Type 2: A Review on Genotype-Phenotype Correlations

Int J Environ Res Public Health. 2021 Apr 30;18(9):4796. doi: 10.3390/ijerph18094796.

Abstract

Wolfram syndrome is a rare neurodegenerative disorder that is typically characterized by diabetes mellitus and optic atrophy. Other common features are diabetes insipidus and hearing loss, but additional less-frequent findings may also be present. The phenotype spectrum is quite wide, and penetrance may be incomplete. The syndrome is progressive, and thus, the clinical picture may change during follow-up. Currently, two different subtypes of this syndrome have been described, and they are associated with two different disease-genes, wolframin (WFS1) and CISD2. These genes encode a transmembrane protein and an endoplasmic reticulum intermembrane protein, respectively. These genes are detected in different organs and account for the pleiotropic features of this syndrome. In this review, we describe the phenotypes of both syndromes and discuss the most pertinent literature about the genotype-phenotype correlation. The clinical presentation of Wolfram syndrome type 1 suggests that the pathogenic variant does not predict the phenotype. There are few papers on Wolfram syndrome type 2 and, thus, predicting the phenotype on the basis of genotype is not yet supported. We also discuss the most pertinent approach to gene analysis.

Keywords: CISD2; ERIS; Wolfram syndrome; diabetes insipidus; diabetes mellitus; genotype-phenotype correlation; molecular genetics; optic atrophy; sensorineural hearing loss; wolframin.

Publication types

  • Review

MeSH terms

  • Genetic Association Studies
  • Genotype
  • Humans
  • Mutation
  • Optic Atrophy*
  • Phenotype
  • Wolfram Syndrome* / genetics